People wary of cholesterol have reason to rejoice since a study has shown that there is another way to get rid of it.
Mark Brown of Wake Forest University School of Medicine said that "cholesterol really can't be broken down."
Cholesterol
Cholesterol is produced by the body (liver) and is essential for normal body functioning.
Advertisement
To get rid of it, it must be excreted, and now Brown and his colleagues have new evidence for an alternate way to deliver cholesterol into the faeces.
The findings revise scientific dogma about cholesterol loss that goes back almost 40 years.
Textbooks say that white blood cells known as macrophages gobble up cholesterol from artery walls.
![Low Cholesterol Diet - PUFA & MUFA]( "Low Cholesterol Diet - PUFA & MUFA")
That cholesterol is then delivered to high-density lipoprotein [HDL, aka good cholesterol], which takes it back to the liver where it goes into bile.
"Bile is necessary under the model to deliver cholesterol to the intestine," said Brown.
In fact, studies in dogs unable to get cholesterol into bile showed that the animals actually experienced an increase in cholesterol loss.
And recent studies in mice showed a similar thing.
Researchers said that an alternative pathway has largely been ignored, and thus scientists have made very little progress in defining the molecular pathways and players involved.
Now, Brown and his colleagues offer new evidence that helps support and clarify this alternate path for cholesterol.
They report that mice made unable to secrete cholesterol into bile through genetic manipulation or surgery still lose cholesterol through the faeces at a normal rate.
Macrophages in those animals also continued to take up cholesterol from blood vessels.
The researchers believe that alternate path delivers cholesterol from the liver to the intestine directly through the bloodstream.
"The classic view of reverse cholesterol transport involved the delivery of peripheral cholesterol via HDL to the liver for secretion into bile. In parallel, we believe that the liver also plays a gatekeeper role for nonbiliary fecal sterol loss by repackaging peripheral cholesterol into nascent plasma lipoproteins that are destined for subsequent intestinal delivery," wrote the researchers.
For the purposes of cholesterol-lowering drug discovery, it may prove fruitful to consider those two pathways as "separate and complementary," said Brown.
The study is published in the July issue of Cell Metabolism.
Source: ANI
Textbooks say that white blood cells known as macrophages gobble up cholesterol from artery walls.
Advertisement
That cholesterol is then delivered to high-density lipoprotein [HDL, aka good cholesterol], which takes it back to the liver where it goes into bile.
"Bile is necessary under the model to deliver cholesterol to the intestine," said Brown.
In fact, studies in dogs unable to get cholesterol into bile showed that the animals actually experienced an increase in cholesterol loss.
And recent studies in mice showed a similar thing.
Researchers said that an alternative pathway has largely been ignored, and thus scientists have made very little progress in defining the molecular pathways and players involved.
Now, Brown and his colleagues offer new evidence that helps support and clarify this alternate path for cholesterol.
They report that mice made unable to secrete cholesterol into bile through genetic manipulation or surgery still lose cholesterol through the faeces at a normal rate.
Macrophages in those animals also continued to take up cholesterol from blood vessels.
The researchers believe that alternate path delivers cholesterol from the liver to the intestine directly through the bloodstream.
"The classic view of reverse cholesterol transport involved the delivery of peripheral cholesterol via HDL to the liver for secretion into bile. In parallel, we believe that the liver also plays a gatekeeper role for nonbiliary fecal sterol loss by repackaging peripheral cholesterol into nascent plasma lipoproteins that are destined for subsequent intestinal delivery," wrote the researchers.
For the purposes of cholesterol-lowering drug discovery, it may prove fruitful to consider those two pathways as "separate and complementary," said Brown.
The study is published in the July issue of Cell Metabolism.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Injury to the white matter explains why football players are at an increased risk for cognitive and behavioral problems later in life.
Located at the South Col, the rocky area between Mount Everest and Lhotse serves as the final campsite for climbers as well as a frozen legacy of hardy microbes.
The new finding is found to be valuable for screening specific medications and treatment against Giardia and other protozoan parasites.
New CRISPR genome-editing strategy was found to have a positive impact in the treatment of inherited retinal diseases such as retinitis pigmentosa.
H3N2 Influenza: The newly developed RT-qPCR Kit to identify influenza, COVID-19 and respiratory virus has got approval from ICMR.